Logo-jrip
Submitted: 13 Sep 2022
Accepted: 10 Dec 2022
ePublished: 09 Feb 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Inj Prev. 2023;12(2): e32139.
doi: 10.34172/jrip.2023.32139

Scopus ID: 85158949305
  Abstract View: 1121
  PDF Download: 622

Original

Prevalence of renal pathological disorders in kidney transplant recipients: an observational study in the north of Iran

Elham Ramezanzadeh 1 ORCID logo, Ali Monfared 1 ORCID logo, Masoud Khosravi 2* ORCID logo, Reyhaneh Ghanbari 2 ORCID logo, Tina Yazdanipour 3 ORCID logo, Ehsan Kazemnezhad Leyli 2 ORCID logo

1 Regenerative Medicine, Organ Procurement and Transplantation Multi-Disciplinary Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
2 Urology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
3 Student Research Committee, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran
*Corresponding Author: Masoud Khosravi, Email: drmasoudkhosravi@gmail.com, , Email: masoud@gums.ac.ir

Abstract

Introduction: There are possible adverse effects and pathological disorders that can occur after kidney transplantation. The prevalence of these outcomes in kidney transplant patients is different worldwide.

Objectives: In this study, we decided to take a general look at the prevalence of pathological disorders in kidney transplant patients undergoing biopsy.

Patients and Methods: This cross-sectional study was conducted on 206 kidney transplant recipients who underwent biopsy of transplanted kidney at Razi medical education center in Rasht city between 2008 and 2019. Information was collected from medical records and interviewing patients. The data were analyzed using SPSS software version 26. They were summarized as the mean (SD) or as median (IQR). The frequency distribution (percentage) was conducted to describe the qualitative variables.

Results: Out of 206 patients, 143 (69.4%) were male and the mean age at transplantation was 46.7±13.6 years. About 42.72% were non-relative donors, 47.57% were brain dead donors and 9.71% were family donors. The most common pathological disorder was nephrotoxic caused by calcineurin inhibitors (CNIs) (41.75%) and the most common type of graft rejection was antibody-dependent graft rejection (46.12%). In terms of transplant outcome, 35.92% of the patients suffered transplant rejection and 23.3% of them died. The results of this study did not show a significant relationship between the administration of immunosuppressive drugs and the pathological disorders.

Conclusion: The present study showed that the most common pathological disorder in kidney transplant patients was CNIs nephrotoxicity, and the most common type of transplant rejection was antibody-dependent transplant rejection.


Implication for health policy/practice/research/medical education:

In a cross-sectional study conducted on 206 kidney transplant patients undergoing biopsy, we found out that the most common pathological disorder in kidney transplant patients was calcineurin inhibitors (CNI) nephrotoxicity (41.75%), and the most common type of transplant rejection was antibody-dependent transplant rejection (46.12%). However, no significant relationship was found between the administration of immunosuppressive drugs and the pathological disorders.

Please cite this paper as: Ramezanzadeh E, Monfared A, Khosravi M, Ghanbari R, Yazdanipour T, Kazemnezhad Leyli E. Prevalence of renal pathological disorders in kidney transplant recipients: an observational study in the north of Iran. J Renal Inj Prev. 2023; 12(2): e32139. doi: 10.34172/jrip.2023.32139.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1122

Your browser does not support the canvas element.


PDF Download: 622

Your browser does not support the canvas element.